Načítá se...

Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization

Recent clinical studies have revealed that a somatic mutation in MAP2K1, causing constitutive activation of MEK1 in osteogenic cells, occurs in melorheostotic bone disease in humans. We have generated a mouse model which expresses an activated form of MEK1 (MEK1DD) specifically in osteoprogenitors p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bone
Hlavní autoři: Fowlkes, John L., Bunn, R. Clay, Ray, Philip D., Kalaitzoglou, Evangelia, Uppuganti, Sasidhar, Unal, Mustafa, Nyman, Jeffry S., Thrailkill, Kathryn M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6914252/
https://ncbi.nlm.nih.gov/pubmed/31689526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2019.115106
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!